Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261075017
Mayo Foundation
Search grants from Mayo Foundation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Semantic Deficits in Temporal Lobe Epilepsy Surgical Patients May Represent A Str
A Human Antibody as an Immunotherapy for Cocaine Abuse (DP1)
CAR &adenoviral gene therapy for diabetic renal disease
Glycan alterations in C.elegans surface mutants
Pharmacologic Regulation of Gene Expression in Leukemia
Recently added grants:
Reducing maternal prenatal depression to improve child cardiovascular health
Imaging sodium and lymphatics in lymphedema
The Role of the Microbiome and Notch Signaling in Esophageal Adenocarcinoma
Leveraging platelet contraction cytometry for immune thrombocytopenia
Prescription opioids, cognitive decline, and Alzheimers disease in older adults
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA075017-008
Application #
7329467
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2006
Total Cost
Indirect Cost
Institution
Name
Mayo Foundation
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CA
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261075017
/ Mayo Foundation
NIH 2003
N01 CA
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261975017
/ Mayo Foundation
Comments
Be the first to comment on this grant